Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

NCT04593277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 549

Last updated 2026-01-23

No results posted yet for this study

Summary

This trial studies how well an interactive survivorship program works in improving healthcare resources in adolescent and young adult cancer survivors. By improving access to survivorship resources, health literacy, self-management skills, and support, an interactive survivorship program may help to improve adherence to adolescent and young adult healthcare guidelines and reduce cancer-related distress.

Conditions

  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • Clinical Stage II Cutaneous Melanoma AJCC v8
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Invasive Malignant Neoplasm
  • Leukemia
  • Lymphoma
  • Malignant Solid Neoplasm
  • Sarcoma
  • Stage I Colorectal Cancer AJCC v8
  • Stage II Colorectal Cancer AJCC v8
  • Stage III Colorectal Cancer AJCC v8
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Thyroid Gland Carcinoma

Interventions

OTHER

Internet Mobile Technology

Use INSPIRE mobile application

OTHER

Internet-Based Intervention

Access to a study-specific control website

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Supportive Care

Receive telehealth stepped care

OTHER

Informational Intervention

Receive printed SCP materials

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • K. Scott Baker · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-23
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593277 on ClinicalTrials.gov